Bulls N' Bears with Matt BirneyAmplia Therapeutics: An oral cancer drug trial with serious results!
Listen to ASX-listed Amplia Therapeutics Managing Director Chris Burns talk to Matt Birney on the Bulls N’ Bears Report about Amplia’s remarkable drug that looks to be having an impact on a known cancer growth protein.
In 1 playlist(s)
Bulls N' Bears with Matt Birney
Matt Birney and Bulls N' Bears sit at the epicentre of the small cap ASX-listed company space in Per…Social links
Follow podcast
Recent clips
Augustus Minerals: Brand new gold discovery – and it’s in granite!
03:07
49 Metals: A $10m gold/silver IPO, old workings everywhere and a big IP anomaly lurking
03:00
Hastings Technology Metals: A rare earths game changer – a mothballed plant that has never fired a shot
02:58